Initially, we studied how PRIMA-1 affects the expression of vascular endothelial growth factor (VEGF) in several different hormone-responsive human breast cancer cell lines, which differ in their expression of estrogen and progesterone receptors (ER, PR), as well as their wtp53/mtp53 expression and content [14]. The gene discussed is PGR; the disease is breast carcinoma.